← Leaderboards
John P Kinsella
University Of Colorado Denver
$11,583,028
Attributed
$12,553,133
Total exposure
10
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$12,553,133 · 10
By mechanism
U01$9,519,233 · 2
P50$2,563,801 · 2
M01$470,099 · 6
Top collaborators
- Steven Herbert Abman1 shared
- Gary R Cutter1 shared
- Robin H Steinhorn1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Robin Shandas$12,521,834
- Bradford J Smith$3,826,386
- Peter M Mourani$3,910,635
- Peter D Sottile$846,030
- Jason Gien$661,500
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsPulmonary HypertensionLung DisorderPlacebosHuman SubjectPremature Infant HumanRandomizedBronchopulmonary DysplasiaSafetyMorbidity - Disease RateMasksHuman Therapy EvaluationBasePregnancyChemopreventionInhaled Nitric OxideDoseAdverse EffectsDesignIncidenceMortality Vital StatisticsLungAffect
Grant awards (22)
Non-Invasive Inhaled NO in Premature Newborns$64,851
P50 · FY2011 · HL · contact PI
Phase II Trial of Sildenafil in Newborns with Persistent Pulmonary Hyptertension$1,293,473
U01 · FY2010 · HL · contact PI
Non-Invasive Inhaled NO in Premature Newborns$455,783
P50 · FY2010 · HL · contact PI
Non-Invasive Inhaled NO in Premature Newborns$648,557
P50 · FY2009 · HL · contact PI
Non-Invasive Inhaled NO in Premature Newborns$597,662
P50 · FY2008 · HL · contact PI
Non-Invasive Inhaled NO in Premature Newborns$503,919
P50 · FY2007 · HL · contact PI
INHALED NITRIC OXIDE FOR PREVENTION OF CHRONIC LUNG DISEASE IN PREMATURE INFANTS$51,250
M01 · FY2007 · RR · contact PI
INHALED NITRIC OXIDE FOR PREVENTION OF CHRONIC LUNG DISEASE IN PREMATURE INFANTS$167,479
M01 · FY2006 · RR · contact PI
Core A-- Clinical Core$98,412
P50 · FY2006 · HL · contact PI
A 7-DAY MULTICENTER TRIAL OF IV SILDENAFIL FOR NEONATES WITH PPHN$5,643
M01 · FY2006 · RR · contact PI
INHALED NITRIC OXIDE FOR PREVENTION OF CHRONIC LUNG DISEASE IN PREMATURE INFANTS$145,426
M01 · FY2005 · RR
Core A-- Clinical Core$97,793
P50 · FY2005 · HL
A 7-DAY MULTICENTER TRIAL OF IV SILDENAFIL FOR NEONATES WITH PPHN$9,286
M01 · FY2005 · RR
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE$1,245,274
U01 · FY2004 · HL
Core A-- Clinical Core$96,824
P50 · FY2004 · HL
Inhaled Nitric Oxide for Prevention of Chronic Lung Disease in Premature Infants$91,015
M01 · FY2004 · RR
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE$1,441,567
U01 · FY2003 · HL
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE$1,764,494
U01 · FY2002 · HL
INTRATRACH R-H CUZNSOD TO PREVENT BPD IN PREM INFANTS$0
M01 · FY2002 · RR
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE$1,803,405
U01 · FY2001 · HL
INHALED NO FOR THE PREVENTION OF CHRONIC LUNG DISEASE$1,971,020
U01 · FY2000 · HL
INTRATRACH R-H CUZNSOD TO PREVENT BPD IN PREM INFANTS$0
M01 · FY2000 · RR